Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmaceutical Litigation topic
No spam. Unsubscribe anytime.
Union County Authorizes Outside Counsel to Pursue Insulin and GLP‑1 Litigation
Summary
The Board approved a contract with Frantz Law Group to investigate and pursue claims against manufacturers and pharmacy benefit managers over insulin and GLP‑1 pricing; the resolution passed unanimously May 28, 2026.
Union County commissioners unanimously approved Resolution 2026‑392 on May 28 authorizing the County Manager to enter into an agreement with Frantz Law Group, APLC, to investigate and pursue litigation against manufacturers and pharmacy benefit managers (PBMs) concerning insulin and GLP‑1 prescription drugs for damages to the county.
Chairman Joseph C. Bodek presented the resolution as county action to evaluate potential claims and litigation avenues; the minutes record no public opposition during the meeting. The motion carried 9‑0.
Why it matters: the resolution permits the county to retain out‑of‑state counsel to investigate whether manufacturers or PBMs caused financial harm to Union County related to insulin and GLP‑1 drugs. The minutes do not include an estimate of potential damages, anticipated costs of litigation, or whether the county would pursue contingency or fee arrangements for the firm. Those details were not specified in the record and may be available in the contract documents.
What the record shows: the Board approved the authorizing resolution in a consent agenda vote. The minutes identify the law firm and the stated litigation subject but do not quote counsel or provide a presentation in the public minutes.
Next steps: the County Manager is authorized to finalize the agreement with Frantz Law Group and to proceed with investigation and potential litigation consistent with the terms of the contract.
